Oncology GALEAS uPCR: ESR1
uPCR Product

ESR1 mutation detection in liquid biopsy samples

GALEAS™ uPCR: ESR1

A qPCR assay with the sensitivity of a digital PCR assay designed for detecting eleven key mutations in the estrogen receptor gene, ESR1.

Accuracy and sensitivity of digital PCR in a qPCR assay

GALEAS uPCR: ESR1 detects eleven of the most prevalent mutations in the estrogen receptor gene, ESR1, known to be associated with endocrine therapy resistance. The assay uses ultrasensitive PCR (uPCR), a Nonacus proprietary technology, to deliver improved sensitivity and specificity over standard qPCR that ensures no wild-type bleed through and data comparable to digital PCR.

Simple to use, and requiring no specialist equipment, it offers laboratories a fast and cost-effective method for the accurate and sensitive detection of ESR1 mutations.

Mutations in the ESR1 gene are known drivers of resistance to standard endocrine therapy and are present in up to 40% of ER+, HER2- metastatic breast cancers1. Liquid biopsy studies have led to a greater understanding of the role these mutations play in resistance and clinical guidelines increasingly support the use of ESR1 testing in metastatic breast cancer2.

 

ESR1 variants covered by GALEAS uPCR: ESR1:
High prevalence: E380Q, D538G, Y537S, Y537N
Low prevalence: S463P, Y537C, L536H, L536R, P535H, L536Q, Y537D

Key features

  • Detects eleven of the most prevalent mutations in the estrogen receptor gene, ESR1, known to be associated with endocrine therapy resistance.
  • Developed for use with cell-free DNA.
  • Delivers improved sensitivity and specificity over standard qPCR.
  • Simple to use, requires no specialist equipment.

Performance

Assay sensitivity and specificity were tested using synthetic controls and commercially available reference standards containing multiple, known ESR1 variants.

ESR1 mutations were detected with a specificity of ≥98% and a sensitivity of ≥90% at mutant allele frequencies (MAF) between 0.04% and 0.33%.

Table 1: Analytical Sensitivity

Determined using synthetic controls (60 replicates; 3 independent qPCR runs). The Limit of Detection (LoD) ranged between 0.04% and 0.33% Mutant Alle Frequency (MAF) at an analytical sensitivity of ≥90% for all targets.

Table 2: Analytical Specificity

Determined using 25 ng of commercial cfDNA wild type reference standard per reaction (75 technical replicates per multiplex). Genomic DNA (gDNA) contamination was shown to have no impact on specificity. Overall ≥98% specificity was obtained for all multiplexes across both cfDNA and gDNA

Table 3: Validation using SensID ESR1 reference set

GALEAS uPCR: ESR1 was validated using the ESR1 reference set from SensID, GmbH at 1%, 0.3% and 0.1% MAF in a background of SensID wild-type cfDNA. 0.1% MAF was detected, and 100% specificity was achieved.

Figure 1: Amplification plot of D538G target showing no wt bleed through.

No wild type bleed through was observed at 1%, 0.3% and 0.1% MAF for any of the ESR1 variants targeted using SensID reference standards. Figure 1 shows an example plot. A) Positive control PC1, B) Positive Control PC1, C) SensID Tube 3 (D538G), 0.3% duplicate repeats, D) wild-type control.

Streamlined workflows; quick and easy protocols

Nonacus uPCR

Sample to data in under 3 hours:

sample
Sample Preparation
pcr-amplification
PCR Amplification and fluorescence read out
analysis
Analysis

Why choose GALEAS uPCR: ESR1?

Accurate and sensitive

Detect mutations in ESR1 with a specificity of ≥98% and a sensitivity of ≥90% at MAFs between 0.04% and 0.33%.

Key variants covered

Detect 11 actionable variants in the ESR1 gene from cell-free DNA in plasma

Results in under 3 hours

A fast, simple qPCR protocol that requires no specialist equipment and can be deployed in almost any molecular laboratory.

*For Research Use Only. Not for use in diagnostic procedures.

MethodQualitative qPCR test
Number of Targets11 ESR1 variants
Sample typecell-free DNA (cfDNA)
Input amount1-25 ng
Kit format32 reactions per multiplex, (accommodates 29 samples when running x 3 controls).
Controls3 positive and 1 negative
Protocol lengthUnder 3 hours

Product Pack SizeCatalogue No.
GALEAS uPCR: ESR196 reactions (32 reactions per multiplex)PCR_GAL_ESR1_96

Which qPCR cyclers have you tested?

Can you tell which mutation in the multiplex is present?

Can you quantify the copy number for the sample with this kit?

What samples should I use for instrument validation

How many samples can I run with the kit?

What is the minimum number of samples I can run at a time?

What is the minimum number of samples I can run at a time to maximise full kit capacity?

Got a question? Get in touch